BSEAGM/EGM30 Sept 2026 · 30 Sept 2026, 04:50 pm

Proceedings of the 33rd Annual General Meeting of the Company held on 30th September, 2026 at 11:30 A.M. and concluded on 12:30 P.M.

Ishita Drugs & Industries Ltd · 524400

✦ AI SummaryMgmt Change

Ishita Drugs & Industries Ltd held its 33rd Annual General Meeting on September 30, 2026, where 32 members attended in person. The meeting approved several resolutions, including the re-appointment of a non-executive director and related party transactions. The company also extended the facility of E-Voting/ Remote Voting to its members.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern5/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ishita Drugs & Industries Ltd - 524400 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Attachments (1)

📄

b33a6d99-463a-463a-b170-881b0c705e4c.pdf

pdf

Download →
View document text
ISHITA DRUGS & INDUSTRIES LTD. Corp. Offts 401, 3rd Eye 11, Opp. farlmal Garden, C. G. Road. Ahmedabad-380006. Ftegd. Office & I:actory : 179/I, \fasna-lyan.a, Tal. Sanand. Dist. : Ahmedabad. E-mall : lshitadmues@mall.com I lnfo@lshltadrufs.com I URL : www.ishitadmuEs.com Phone : +917226995613/ +9179 4002 3839 Date: 30.09.2026 Department of Corporate Services, BSE Limited. Floor No. 25, Phiroze jeejeebhoy Towers, Dalal Street, Mumbai-400 001. Scrip code: 524400 Dear Sir/Madam, Sub: Submission of Proceeding of the 33rd Annual General Meeting of the Company held on 30th Sentembet'. 2026 Ppursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) RRegulatious, 2015, Please find enclosed a summary of the proceedings of the 33rd Armual General Meeting (AGM) of the Company held on Wednesday, 30th September, 2026 at 11:30 a.in. at "Manthan", Hotel Krsna Lila, Nr. Rexroth Bosch, Village Iyava, Taluka Sanand, Sanand Viramgam Highway, Gujarat 382170. Kindly take the same on your record. T.hanking You, For, ]shita Drugs and Industries Limited. |agdish AgrawaL Managing Director DIN: 01031687 Encl: As Above •OuT 6asi¢ dr+gs in tfic savice Of hrmanrty coorfuwide ' CIN No. L24231GJ1992PLC017054 D a a D-U-N€ Niimbei -65rgl8ro359 ISHITA DRUGS & INDUSTRIES LTD. Carp. Offi: 401, 3rd Eye 11, Opp. Parimal Garden, C. G. Road, Alimedabad-380006. IR.giv. Office & Factor)I : 179/I. \fasna-lyanq Tal. Sanand, Disc. : Ahmedabad. E-mall : ishitadnigs@gmail.egm I lnfo®ishitadruEs.com I URL : www.ishitadmuErs.com Phone : +9 I 722699561 3/ 14/ I 5 +91 79 4002 3839 Summarv of I)roceedings Of 33rd Annual General Meetim! of ]shita Diufrs and Industries Limited f`the Comnanv'1 TThis is to inform you that 33ed Annual General Meeting (AGM) of the members of the Company was held on Wednesday, 30th September, 2026 at 1130 a.in. at "Manthan", Hotel Krsna Lila, Nr. Rexroth Bosch, VIllage lyava, Taluka Sanand, Sanand Viramgam Highway, Gujarat 382170. Shri Jagdishprasad Agrawal, Chairman, welcomed the other present members and introduced the Director(s) sitting on the dias. There were 32 (Thirty -Two) members who attended the meeting in person (including bodies corporate through their representatives), as per records of attendance. T`he requisite Quorum being present, the Chairman called the meeting to order. TThe Chairman briefed everyone about the financial performance of the Company for the financial year ended 31st March, 2026 and its future outlook. The Chairman also brief about the status of the undergoing upgradation project of manufacturing facility. Thereafter celtain members present in the said meeting had given their suggestions and asked questions which were replied to, by the Chairman. The followmg resolutlons, as set out in the Nottce convening the AGM, were proposed and seconded by the members: Ordinarv BL]siness: 1. To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended 31st March, 2026, together with the Reports of Board of INrectors and Auditors thereon. 2. Appointment of the Auditors of the Company for the year 2026-27 and to fix their remuneration. SDecia[ Ehaness: 3. To approve re-appointment of Mrs. Abha Agrawal tl)IN: 01589479) as a Non-Executive Non-Independent Director of the Company post attaining the age of 75 years, and who retires by rotation, being eligible offers herself for re-appointment. (Special Resolution) 4. To Approve the Related Party Transactions with lshita Pharmaceuticals. (Ordinary Resolution) •Ou;T basic dr8s in chL; sonhee Of hunendy ulor[dwi4p CIN No. L24231GJ1992PLC017054 D 8 8 D-U-N-S Number 65J)18ro359 lsHITA DRUGS & INDUSTRIES LTD. Corp. Off.: 401. 3rd Eye 11, Opp. Parimal Garden. C. G. Road, Ahmedabad-380006. Regd. Ofnce & Fac.ory : 179/I, Vasna-Iyava. Tal. Sanand, Disc. : Ahmedabad. E-mall : ail.com I lnfo@ishitadruf!s.com I URL : www.ishitadrues.com Phone : +91 7226995613/ I 4/ 15 +9179 4002 3839 5. To Approve the Related Party Transactions with Anvi Lifesciences Private Limited. (Ordinary Resolution) The Chairman further informed the Members that pursuant to the provision of Section 108 of the Companies Act, 2013, and applicable rules made there under and pursuant to the applicable Regulation of SEBI (LODR), 2015, the Company had extended the facility of E-Voting/ Remote Voting to the Members through NSDL in respect of the businesses to be transacted at the said Meeting. The E-Voting commenced on 27th September, 2026 at 09:00 a.in. (IST) and ended on 29th September, 2026 at 05:00 p.in. (lsT) Meenu Maheshwari, Practicing Company Secretary at Meenu Maheshwari & Associates was appointed as the Scrutinizer by the Board for scrutinizing the e- voting process. The Chairman informed the members that the Company has arranged for voting through Ballot papers on all the items to be transacted at the Meeting, for the members who have not cast their votes through e-voting. Thereafter the Chairman asked for the voting process to begin and requested the Scrutinizer to conduct the voting in an orderly manner. After all the members cast their votes, the Chairman informed the members that the consolidated results of E-voting and physical voting at the AGM, will be declared within 48 hours from the conclusion of the meeting and also be intimated to stock exchange(s) and posted on the website of the Company. The Meeting was declared closed on the completion of the voting process. The Chairman concluded the meeting with a vote of thanks to all the members present at the meeting at 12:30 p.in. For, ]shita Drugs and Industries Limited. ]agdish Agrawal Managing Director DIN: 01031687 •our 6asi¢ dru8S in the Sewi¢e Of hrmandy zilofdwide CIN No. L24231GJ1992PLC017054 D & a D-U-N-S Number 65J)18J)359